2004
DOI: 10.1194/jlr.m400081-jlr200
|View full text |Cite
|
Sign up to set email alerts
|

Benzophenone-containing cholesterol surrogates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2005
2005
2012
2012

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 22 publications
(31 citation statements)
references
References 61 publications
(63 reference statements)
0
30
0
Order By: Relevance
“…Effect of SUV lipid composition on the α-helical content of proSCP-2 and SCP-2 N-terminal peptides upon membrane interaction. Circular dichroism spectra were obtained as described in Experimental Procedures: (A and B) peptide [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] Pro, (C and D) peptide Pro, (E and F) peptide Colocalization of Cy5-SCP-2 and Cy5-proSCP-2 with a plasma membrane marker in L cells. L cells were incubated in the presence of Cy5-SCP-2 (A-D) or Cy5-proSCP-2 (E-H) and the plasma membrane marker, AlexaFluor 488-cholera toxin B (AF488-CTB), and examined by laser scanning confocal microscopy (LSCM) as described in Experimental Procedures.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Effect of SUV lipid composition on the α-helical content of proSCP-2 and SCP-2 N-terminal peptides upon membrane interaction. Circular dichroism spectra were obtained as described in Experimental Procedures: (A and B) peptide [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] Pro, (C and D) peptide Pro, (E and F) peptide Colocalization of Cy5-SCP-2 and Cy5-proSCP-2 with a plasma membrane marker in L cells. L cells were incubated in the presence of Cy5-SCP-2 (A-D) or Cy5-proSCP-2 (E-H) and the plasma membrane marker, AlexaFluor 488-cholera toxin B (AF488-CTB), and examined by laser scanning confocal microscopy (LSCM) as described in Experimental Procedures.…”
Section: Discussionmentioning
confidence: 99%
“…A 41-kDa fragment of peroxin 5 [Pex5p(C)] comprising residues 235-602 and encompassing the sevenpredicted tetratricopeptide repeat (TPR) region as well as the peroxisomal targeting signal-1 (PTS-1) binding region of human Pex5p was generated and purified by J. M. Berg (National Institutes of Health) (18). Free cholesterol benzophenone (FCBP) was synthesized by T. A. Spencer (Department of Chemistry, Dartmouth College) (19). Radiolabelled free cholesterol benzophenone ([ 3 H]FCBP) was prepared for our laboratory by Moravek Biochemicals (Brea, CA) utilizing a procedure (20) that incorporates 3 H at position C-3 of the cholesterol moiety.…”
Section: Experimental Procedures Materialsmentioning
confidence: 99%
“…We have been preparing benzophenone-containing analogues of sterols 1 and phospholipids 2 for use as photoaffinity labelling agents in studies of cellular cholesterol efflux and HDL formation. [3][4][5] In particular, the cholesterol analogue 1, known as FCBP, 3 and the fatty acid analogue 2 ( Figure 1), 2 were required in radioactive form for use as biochemical research tools.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the syntheses of benzophenone-containing PC analogues and of benzophenone-containing cholesterol surrogates have been reported. 43,44 The benzophenone-derivatized sterols were shown to compete with cholesterol for apolipoprotein A-I-induced cellular efflux. 44 3-Trifluoromethyl-3-phenyl diazirines (TPD) generate carbenes upon UV light exposure that have a life time in the order of nanoseconds.…”
Section: Photoactivatable Lipid Crosslinkers: Properties and Applicatmentioning
confidence: 99%
“…43,44 The benzophenone-derivatized sterols were shown to compete with cholesterol for apolipoprotein A-I-induced cellular efflux. 44 3-Trifluoromethyl-3-phenyl diazirines (TPD) generate carbenes upon UV light exposure that have a life time in the order of nanoseconds. 45 No intramolecular rearrangements are observed and they insert in any type of bond, including non-reactive C-H bonds.…”
Section: Photoactivatable Lipid Crosslinkers: Properties and Applicatmentioning
confidence: 99%